ES2083490T3 - 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio. - Google Patents

3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio.

Info

Publication number
ES2083490T3
ES2083490T3 ES91113017T ES91113017T ES2083490T3 ES 2083490 T3 ES2083490 T3 ES 2083490T3 ES 91113017 T ES91113017 T ES 91113017T ES 91113017 T ES91113017 T ES 91113017T ES 2083490 T3 ES2083490 T3 ES 2083490T3
Authority
ES
Spain
Prior art keywords
tsh
treatment
suppression
tironina
diyodo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91113017T
Other languages
English (en)
Inventor
Claus Dr Rer Nat Dipl-Bi Horst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Application granted granted Critical
Publication of ES2083490T3 publication Critical patent/ES2083490T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radio Relay Systems (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Microwave Tubes (AREA)

Abstract

EL MEDIO PARA LA SUPRESION TSH Y TRATAMIENTO DEL ESTRUMA, CONTIENE UNA DOSIS ACTIVA TERAPEUTICA DE 3,5-DIIOD-L-TIRONIN Y PRODUCTOS AUXILIARES GALENICOS USUALES. LOS MEDIOS CONTENIENDO ACCION METABOLICA BAJA MUESTRAN HASTA AHORA EN APLICACIONES DE LARGO PLAZO UN EFECTO FUERTE SOBRE EL NIVEL TSH SIN EFECTOS ASOCIADOS NO DESEADOS.
ES91113017T 1990-08-23 1991-08-02 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio. Expired - Lifetime ES2083490T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4026600A DE4026600A1 (de) 1990-08-23 1990-08-23 Mittel zur tsh-suppression und behandlung von struma

Publications (1)

Publication Number Publication Date
ES2083490T3 true ES2083490T3 (es) 1996-04-16

Family

ID=6412712

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91113017T Expired - Lifetime ES2083490T3 (es) 1990-08-23 1991-08-02 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio.

Country Status (8)

Country Link
US (1) US5200428A (es)
EP (1) EP0472033B1 (es)
JP (1) JP2709761B2 (es)
AT (1) ATE131729T1 (es)
DE (2) DE4026600A1 (es)
DK (1) DK0472033T3 (es)
ES (1) ES2083490T3 (es)
GR (1) GR3018705T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
US6740680B1 (en) * 1999-04-26 2004-05-25 Becton Pharma, Inc. Pharmaceutical compositions to tetrac and methods of use thereof
ITMI20011401A1 (it) 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
ITRM20030363A1 (it) * 2003-07-24 2005-01-25 Fernando Goglia Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
DE102010018514A1 (de) 2010-04-27 2011-10-27 Nordischer Maschinenbau Rud. Baader Gmbh + Co Kg Vorrichtung und Verfahren zum Trennen einer Oberflächenschicht von tierischen Nahrungsmittelprodukten
CN104784427A (zh) * 2015-05-19 2015-07-22 李汶峰 一种治疗甲状腺囊肿的中药

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102136A (en) * 1959-06-24 1963-08-27 Warner Lambert Pharmaceutical Process of preparing diiodinated analogs of thyronine
US4673691A (en) * 1984-11-05 1987-06-16 Nicholas Bachynsky Human weight loss inducing method
CN1011118B (zh) * 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法

Also Published As

Publication number Publication date
DK0472033T3 (da) 1996-01-29
EP0472033B1 (de) 1995-12-20
DE59107111D1 (de) 1996-02-01
EP0472033A2 (de) 1992-02-26
JPH04244022A (ja) 1992-09-01
US5200428A (en) 1993-04-06
JP2709761B2 (ja) 1998-02-04
GR3018705T3 (en) 1996-04-30
DE4026600A1 (de) 1992-02-27
DE4026600C2 (es) 1992-06-04
EP0472033A3 (en) 1992-07-15
ATE131729T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
ES2159591T3 (es) Composicion de liberacion controlada.
ES2106794T3 (es) Utilizacion del inositol-trifosfato para el tratamiento de inflamaciones.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
KR920019342A (ko) 골질환 치료제
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
IT1206341B (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
ES236606Y (es) Soporte formado por una parte por una jaula calada destinadaprincipalmente para contener un bloque de producto para la desinfeccion y la eliminacion de olores de tazas de cuarto de aseo.
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
ES2083490T3 (es) 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio.
DE59001121D1 (en) Antacidatabletten.
ES2103825T3 (es) Composiciones farmaceuticas que contienen 5-difluorometoxi-2-(3,4-dimetoxi-2-piridil)-metilsulfinil)bencimidazol y un agente anti-helicobacter para el tratamiento de trastornos gastrointestinales.
DK0469064T3 (da) Anvendelse af C-20- til C-26-alifatiske alkoholer til fremstilling af et lægemiddel til behandling af virusinfektioner
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
JPS51128438A (en) An antibacterial drug against fish diseases
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
IT7921958A0 (it) Agente per attirare insetti composito, per i maschi della nottua del cavolo e procedimento per preparare i suoi principi attivi.
JPS5215809A (en) Spray for sterilization and deodorization
JPS5212925A (en) A plant disease controlling agent
KR900012622A (ko) 피부질환치료 조성물
SU1711368A1 (ru) Репеллент
KR930019216A (ko) 종양 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 472033

Country of ref document: ES